Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-01-13 6:13 pm Purchase |
2022-01-07 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 6,491,099 5.200% |
6,491,099![]() (New Position) |
Filing History |
2021-12-30 12:26 pm Purchase |
2021-12-28 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 9,972,877 5.100% |
9,972,877![]() (New Position) |
Filing History |
2021-12-23 5:34 pm Purchase |
2021-12-21 | 13G | Rezolute, Inc. RZLT |
Stonepine Capital Management, LLC | 789,326 5.100% |
789,326![]() (New Position) |
Filing History |
2021-12-23 5:33 pm Purchase |
2021-12-20 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 833,537 5.200% |
833,537![]() (New Position) |
Filing History |
2021-11-19 4:55 pm Purchase |
2021-11-10 | 13G | Yumanity Therapeutics, Inc. YMTX |
Stonepine Capital Management, LLC | 91,946 6.200% |
91,946![]() (New Position) |
Filing History |
2021-08-09 4:06 pm Sale |
2021-08-05 | 13G | Chiasma, Inc. CHMA |
Stonepine Capital Management, LLC | 0 0.000% |
-6,770,000![]() (Position Closed) |
Filing History |
2021-07-09 5:06 pm Purchase |
2021-07-02 | 13G | Strongbridge Biopharma plc SBBP |
Stonepine Capital Management, LLC | 3,566,964 5.300% |
3,566,964![]() (New Position) |
Filing History |
2021-06-14 4:49 pm Purchase |
2021-06-08 | 13G | Conformis, Inc. CFMS |
Stonepine Capital Management, LLC | 366,475 5.000% |
366,475![]() (New Position) |
Filing History |
2021-05-14 4:23 pm Purchase |
2021-05-06 | 13G | Chiasma, Inc. CHMA |
Stonepine Capital Management, LLC | 6,770,000 11.700% |
2,907,517![]() (+75.28%) |
Filing History |
2021-04-29 4:48 pm Purchase |
2021-04-20 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 3,500,000 5.300% |
3,500,000![]() (New Position) |
Filing History |
2021-03-17 7:09 pm Purchase |
2021-03-08 | 13G | Chiasma, Inc. CHMA |
Stonepine Capital Management, LLC | 3,862,483 6.700% |
3,862,483![]() (New Position) |
Filing History |
2021-03-01 6:06 pm Purchase |
2021-02-25 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 3,408,849 7.600% |
2,600,418![]() (+321.66%) |
Filing History |
2021-02-18 7:48 pm Purchase |
2021-01-27 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 543,781 6.900% |
332,221![]() (+157.03%) |
Filing History |
2021-02-12 5:09 pm Sale |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 1,530,650 7.700% |
-6,303![]() (-0.41%) |
Filing History |
2021-02-12 5:08 pm Sale |
2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Stonepine Capital Management, LLC | 0 0.000% |
-334,272![]() (Position Closed) |
Filing History |
2021-02-12 5:07 pm Purchase |
2020-12-31 | 13G | NEOS THERAPEUTICS INC NEOS |
Stonepine Capital Management, LLC | 4,962,657 9.970% |
103,768![]() (+2.14%) |
Filing History |
2021-02-12 5:07 pm Sale |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
Stonepine Capital Management, LLC | 800,000 0.900% |
-4,347,744![]() (-84.46%) |
Filing History |
2021-02-12 5:06 pm Sale |
2020-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management, LLC | 0 0.000% |
-277,277![]() (Position Closed) |
Filing History |
2021-02-12 5:05 pm Unchanged |
2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Stonepine Capital Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2021-02-12 5:04 pm Purchase |
2020-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
Stonepine Capital Management, LLC | 1,150,259 6.100% |
350,259![]() (+43.78%) |
Filing History |